A real-world study of combined modality therapy for early-stage Hodgkin lymphoma: too little treatment impacts outcome

Multiple clinical trials have assessed de-escalation strategies from combined modality therapy (CMT) to chemotherapy-alone for the treatment of early-stage classical Hodgkin lymphoma (cHL), confirming similar outcomes. The application of these data to the real-world is limited, however. We conducted...

Descripción completa

Detalles Bibliográficos
Autores principales: Chohan, Karan L., Young, Jason R., Lester, Scott, Alhaj Moustafa, Muhamad, Rosenthal, Allison, Tun, Han W., Hoppe, Bradford S., Johnston, Patrick B., Micallef, Ivana N., Habermann, Thomas M., Ansell, Stephen M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Clinical Trials and Observations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327542/
https://www.ncbi.nlm.nih.gov/pubmed/35617689
http://dx.doi.org/10.1182/bloodadvances.2022007363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327542/
https://www.ncbi.nlm.nih.gov/pubmed/35617689
http://dx.doi.org/10.1182/bloodadvances.2022007363

Ejemplares similares